| scholarly article | Q13442814 |
| P50 | author | Johan Neyts | Q29460378 |
| Maria São José Nascimento | Q40324882 | ||
| Dirk Jochmans | Q56450393 | ||
| Joana Rocha-Pereira | Q56861678 | ||
| P2093 | author name string | Q Ma | |
| R Hilgenfeld | |||
| M S J Nascimento | |||
| P2860 | cites work | Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes | Q27619756 |
| Crystal Structures of Enterovirus 71 3C Protease Complexed with Rupintrivir Reveal the Roles of Catalytically Important Residues | Q27671472 | ||
| Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. | Q27671667 | ||
| Structural Basis of Substrate Specificity and Protease Inhibition in Norwalk Virus | Q27676085 | ||
| 3C Protease of Enterovirus 68: Structure-Based Design of Michael Acceptor Inhibitors and Their Broad-Spectrum Antiviral Effects against Picornaviruses | Q27676219 | ||
| Structure of a Murine Norovirus NS6 Protease-Product Complex Revealed by Adventitious Crystallisation | Q27681097 | ||
| Norovirus gastroenteritis in immunocompromised patients | Q27694610 | ||
| Coot: model-building tools for molecular graphics | Q27860505 | ||
| The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling | Q27860637 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions | Q27861128 | ||
| Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions | Q28276503 | ||
| In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease | Q28343611 | ||
| Statistical estimations in enzyme kinetics | Q29620206 | ||
| In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease | Q30443266 | ||
| Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature | Q31105046 | ||
| Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assay | Q34112325 | ||
| The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro | Q34504825 | ||
| Favipiravir (T-705) inhibits in vitro norovirus replication | Q34640499 | ||
| X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution | Q34647772 | ||
| Systematic literature review of role of noroviruses in sporadic gastroenteritis | Q34804404 | ||
| Murine norovirus: a model system to study norovirus biology and pathogenesis | Q36477975 | ||
| Potential use of antiviral agents in polio eradication | Q36944919 | ||
| Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected] | Q37093418 | ||
| The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model | Q37252661 | ||
| A three-dimensional model to analyze drug-drug interactions | Q37794779 | ||
| Inhibition of norovirus replication by the nucleoside analogue 2'-C-methylcytidine | Q39259925 | ||
| Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak | Q40289488 | ||
| Selecting and characterizing drug-resistant hepatitis C virus replicon | Q42286495 | ||
| A continuous assay for foot-and-mouth disease virus 3C protease activity | Q45401862 | ||
| The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. | Q47922235 | ||
| Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. | Q51157690 | ||
| Norovirus in a Dutch tertiary care hospital (2002-2007): frequent nosocomial transmission and dominance of GIIb strains in young children | Q83193956 | ||
| Norovirus gastroenteritis | Q84800851 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | norovirus | Q1142751 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 4675-4681 | |
| P577 | publication date | 2014-06-02 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon | |
| P478 | volume | 58 |
| Q38835886 | A Cell-based Fluorescence Resonance Energy Transfer (FRET) Sensor Reveals Inter- and Intragenogroup Variations in Norovirus Protease Activity and Polyprotein Cleavage |
| Q91718477 | A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase |
| Q36440189 | Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal Mutagenesis |
| Q37101808 | Anti-norovirus therapeutics: a patent review (2010-2015). |
| Q64115696 | Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses |
| Q29248430 | Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions |
| Q37062340 | Current tools for norovirus drug discovery |
| Q38825350 | Enteroviral proteases: structure, host interactions and pathogenicity. |
| Q90748454 | Norovirus antivirals: Where are we now? |
| Q37517465 | Recent Advances in the Discovery of Norovirus Therapeutics |
| Q26796360 | Role of Marine Natural Products in the Genesis of Antiviral Agents |
| Q52659751 | Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells In Vitro. |
| Q37401695 | Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds |
| Q40044140 | Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future |
| Q91767093 | Viral replicons as valuable tools for drug discovery |
Search more.